Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Inv. presentation
Appointed director

Verrica Pharmaceuticals Inc. (VRCA) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/24/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/12/2023 4 Ballaron Craig (Director) has filed a Form 4 on Verrica Pharmaceuticals Inc.
Txns: Granted 10,384 options to buy @ $5.7, valued at $59.2k
06/12/2023 4 Eichenfield Lawrence (Director) has filed a Form 4 on Verrica Pharmaceuticals Inc.
Txns: Granted 10,384 options to buy @ $5.7, valued at $59.2k
06/12/2023 4 Nguyen Diem (Director) has filed a Form 4 on Verrica Pharmaceuticals Inc.
Txns: Granted 10,384 options to buy @ $5.7, valued at $59.2k
06/12/2023 4 PRYGOCKI MARK A SR (Director) has filed a Form 4 on Verrica Pharmaceuticals Inc.
Txns: Granted 10,384 options to buy @ $5.7, valued at $59.2k
07/11/2022 4 Hayes Christopher G. (Chief Legal Officer) has filed a Form 4 on Verrica Pharmaceuticals Inc.
Txns: Bought 7,500 shares @ $3.4, valued at $25.5k
07/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/05/2022 4 Hayes Christopher G. (Chief Legal Officer) has filed a Form 4 on Verrica Pharmaceuticals Inc.
Txns: Bought 5,714 shares @ $2.1, valued at $12k
07/05/2022 4 White Ted (President and CEO) has filed a Form 4 on Verrica Pharmaceuticals Inc.
Txns: Bought 23,809 shares @ $2.1, valued at $50k
07/05/2022 4 Goldenberg Gary (Chief Medical Officer) has filed a Form 4 on Verrica Pharmaceuticals Inc.
Txns: Bought 23,809 shares @ $2.1, valued at $50k
07/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/25/2022 4 Hayes Christopher G. (Chief Legal Officer) has filed a Form 4 on Verrica Pharmaceuticals Inc.
Txns: Granted 75,000 options to buy @ $8, valued at $600k
02/25/2022 4 Goldenberg Gary (Chief Medical Officer) has filed a Form 4 on Verrica Pharmaceuticals Inc.
Txns: Granted 75,000 options to buy @ $8, valued at $600k
02/25/2022 4 Kohler Terry (CFO) has filed a Form 4 on Verrica Pharmaceuticals Inc.
Txns: Granted 75,000 options to buy @ $8, valued at $600k
02/25/2022 4 Bonaccorso Joe (Chief Commercial Officer) has filed a Form 4 on Verrica Pharmaceuticals Inc.
Txns: Granted 75,000 options to buy @ $8, valued at $600k
02/25/2022 4 White Ted (President and CEO) has filed a Form 4 on Verrica Pharmaceuticals Inc.
Txns: Granted 200,000 options to buy @ $8, valued at $1.6M
12/06/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/20/2021 4 Kohler Terry (CFO) has filed a Form 4 on Verrica Pharmaceuticals Inc.
Txns: Granted 125,000 options to buy @ $10.28, valued at $1.3M
07/20/2021 3 Kohler Terry (CFO) has filed a Form 3 on Verrica Pharmaceuticals Inc.
06/17/2021 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/17/2021 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/17/2021 4/A Ballaron Craig (Director) has filed a Form 4 on Verrica Pharmaceuticals Inc.
Txns: Granted 8,109 options to buy @ $10.56, valued at $85.6k
06/17/2021 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/14/2021 4 Ballaron Craig (Director) has filed a Form 4 on Verrica Pharmaceuticals Inc.
Txns: Granted 5,834 options to buy @ $10.56, valued at $61.6k
06/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy